Doolub Gemina, Iannaccone Mario, Rab Tanveer, Routledge Helen, Aminian Adel, Chevalier Bernard, Hildick-Smith David, Jacobs Lotte, Kobo Ofer, Roguin Ariel, Chieffo Alaide, Mamas Mamas A
Translational Health Sciences, University of Bristol, Bristol, UK.
Keele Cardiovascular Research Group, Keele University, Keele, UK.
Catheter Cardiovasc Interv. 2023 Sep;102(3):430-439. doi: 10.1002/ccd.30770. Epub 2023 Jul 18.
Percutaneous coronary intervention (PCI) for bifurcation lesions can be technically challenging and is associated with higher risk. There is little data on sex-based differences in strategy and outcomes in bifurcation PCI.
We sought to assess whether differences exist between women and men in the treatment and outcomes of bifurcation PCI.
We collected data on 4006 patients undergoing bifurcation PCI, from the e-ULTIMASTER study, a prospective, multicentre study enrolling patients from 2014 to 2018. We divided the bifurcation cohort according to sex, with 1-year follow-up of outcomes (target lesion failure [TLF], target vessel failure [TVF], and patient-oriented composite endpoint [POCE]).
Women were older (69.2 ± 10.9 years vs. 64.4 ± 11.0 years), with a greater burden of cardiovascular comorbidities. For true and non-true bifurcation lesions, women and men were equally likely to undergo a single stent approach (true: 63.2% vs. 63.6%, p = 0.79, non-true: 95.4% vs. 94.3%, p = 0.32), with similar rates of final kissing balloon (FKB) (37.2% vs. 35.5%, p = 0.36) and proximal optimization (POT) (34.4% vs. 34.2%, p = 0.93) in cases where two stents were used. Lastly, after propensity score matching, there was no difference between women and men in the incidence of the composite endpoints of TLF (5.5% vs. 5.2%, RR 1.05 [95% CI 0.77-1.44], p = 0.75), TVF (6.2% vs. 6.3%, RR 0.99 [95% CI 0.74-1.32], p = 0.96), and POCE (9.9% vs. 9.5%, RR 1.05 [95% CI 0.83-1.31], p = 0.70).
In this contemporary, real-world study of bifurcation PCI, we report no difference in stent strategy between women and men, with similar outcomes at 1-year.
分叉病变的经皮冠状动脉介入治疗(PCI)在技术上具有挑战性,且风险较高。关于分叉病变PCI策略和结果的性别差异数据较少。
我们旨在评估女性和男性在分叉病变PCI治疗及结果方面是否存在差异。
我们从e-ULTIMASTER研究中收集了4006例接受分叉病变PCI患者的数据,该研究是一项前瞻性、多中心研究,于2014年至2018年招募患者。我们根据性别对分叉病变队列进行划分,并对结果进行1年随访(靶病变失败[TLF]、靶血管失败[TVF]和以患者为导向的复合终点[POCE])。
女性年龄较大(69.2±10.9岁 vs. 64.4±11.0岁),心血管合并症负担较重。对于真性和非真性分叉病变,女性和男性接受单支架置入术的可能性相同(真性:63.2% vs. 63.6%,p = 0.79;非真性:95.4% vs. 94.3%,p = 0.32),在使用双支架的情况下,最终球囊亲吻(FKB)率(37.2% vs. 35.5%,p = 0.36)和近端优化(POT)率(34.4% vs. 34.2%,p = 0.93)相似。最后,在倾向评分匹配后,女性和男性在TLF复合终点发生率(5.5% vs. 5.2%,RR 1.05[95%CI 0.77 - 1.44],p = 0.75)、TVF(6.2% vs. 6.3%,RR 0.99[95%CI 0.74 - 1.32],p = 0.96)和POCE(9.9% vs. 9.5%,RR 1.05[95%CI 0.83 - 1.31],p = 0.70)方面没有差异。
在这项关于分叉病变PCI的当代真实世界研究中,我们报告女性和男性在支架策略上没有差异,1年时结果相似。